Women who use taxane chemotherapy agents may be at a higher risk to develop epiphora, optic neuropathy and cystoid macular edema, according to a study.
“Our study showed that although rare, taxane chemotherapy drugs can increase the risk of ocular adverse events such as cystoid macular edema, optic neuropathy and epiphora. It is important that both oncologists and ophthalmologists are aware of these side effects when counseling patients on the risks of taxane chemotherapy,” study author Mohit Sodhi, BSc, MSc, told Healio/OSN. “Early identification of such events may help in